I will be. Quite happy to add more to my position while this is overlooked by the market. EPP revenues over the next few years will easily support a higher stock price than this and any success in clinical trials will add to that.
Ann: Financial Results Half Year - Webinar Announcement, page-5
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.65 |
Change
0.590(3.92%) |
Mkt cap ! $783.7M | |||
| Open | High | Low | Value | Volume |
| $15.27 | $15.65 | $15.05 | $967.0K | 62.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 227 | $15.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.65 | 999 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |